Methotrexate News and Research

RSS
Methotrexate is an antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.

Methotrexate is approved by the Food and Drug Administration (FDA) to be used by itself to treat the following types of gestational trophoblastic tumors, Chorioadenoma destruens, Choriocarcinoma, Hydatidiform mole. Methotrexate is also approved to be used alone or with other drugs to treat acute lymphoblastic leukemia (ALL) that has spread to the central nervous system (CNS) or to keep it from spreading there, and to treat the following, breast cancer, certain types of head and neck cancer, lung cancer, advanced non-Hodgkin lymphoma (NHL), advanced mycosis fungoides (a type of cutaneous T-cell lymphoma), osteosarcoma that has not spread to other parts of the body, following surgery to remove the primary tumor. Methotrexate is also approved to treat the following non-cancer conditions, rheumatoid arthritis, severe psoriasis.
NCCN survey shows cancer drug shortages continue despite efforts

NCCN survey shows cancer drug shortages continue despite efforts

The standard of care and recent advancements in the control of skin inflammation

The standard of care and recent advancements in the control of skin inflammation

Are inflammatory bowel disease patients more at risk of colorectal cancer?

Are inflammatory bowel disease patients more at risk of colorectal cancer?

A novel pharmacology modeling approach to monitor acute lymphoblastic leukemia treatment

A novel pharmacology modeling approach to monitor acute lymphoblastic leukemia treatment

New drug delivery system may revolutionize treatment of ectopic pregnancy

New drug delivery system may revolutionize treatment of ectopic pregnancy

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

New standard more effective at preventing graft-versus-host disease

New standard more effective at preventing graft-versus-host disease

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Cardiovascular comobidities in RA patients

Cardiovascular comobidities in RA patients

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Study shows the potential of TAp63 as a new therapeutic target for rheumatoid arthritis

Study shows the potential of TAp63 as a new therapeutic target for rheumatoid arthritis

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease

Scientists find a good treatment target for pulmonary hypertension

Scientists find a good treatment target for pulmonary hypertension

Investigating the impact of COVID-19 vaccinations in immunocompromised adult patients

Investigating the impact of COVID-19 vaccinations in immunocompromised adult patients

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

Part II: The state of the abortion debate 50 years after ‘Roe’

Part II: The state of the abortion debate 50 years after ‘Roe’

Study analyzes the viability of new nanomolecule as drug delivery vehicle

Study analyzes the viability of new nanomolecule as drug delivery vehicle

Research suggests people on rheumatoid arthritis drugs show weaker response to SARS-CoV-2 vaccines

Research suggests people on rheumatoid arthritis drugs show weaker response to SARS-CoV-2 vaccines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.